Activator protein-2α mediates carbon monoxide-induced stromal cell-derived factor-1α expression and vascularization

Heng-Huei Lin1, Yen-Hui Chen, Ming-Tsai Chiang

  • 1Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei 115, Taiwan, ROC.

Insights

Carbon monoxide (CO) enhances heart repair after ischemic injury by upregulating stromal cell-derived factor-1α (SDF-1α) through the AKT/activator protein 2α (AP-2α) pathway. This mechanism promotes neovascularization and improves cardiac function.

Area of Science:

  • Cardiovascular Research
  • Molecular Cardiology
  • Regenerative Medicine

Background:

  • Increased cardiac stromal cell-derived factor-1α (SDF-1α) expression aids myocardial repair post-ischemia.
  • Heme oxygenase-1 and carbon monoxide (CO) induce SDF-1α, but the mechanism is unclear.

Purpose of the Study:

  • Investigate the signaling pathway mediating CO-induced SDF-1α expression.
  • Identify the transcriptional factor responsible for CO-induced SDF-1α gene expression and cardioprotection.

Main Methods:

  • Utilized primary neonatal cardiomyocytes, H9C2 cardiomyoblasts, and a mouse model of myocardial infarction.
  • Employed promoter luciferase-reporter assays, electrophoretic mobility shift assays, and chromatin immunoprecipitation.
  • Assessed the effects of CO treatment, AKT inhibition, AP-2α knockdown, and lentiviral gene silencing.

Main Results:

  • CO dose-dependently induced SDF-1α expression via activator protein 2α (AP-2α) transcriptional activity.
  • AP-2α induction by CO was dependent on protein kinase B (AKT) signaling.
  • CO treatment in mice improved neovascularization and cardiac function post-infarction, effects dependent on AP-2α.

Conclusions:

  • AKT-dependent upregulation of AP-2α is crucial for CO-induced SDF-1α expression.
  • This pathway is essential for mediating myocardial repair and improving cardiac function after ischemic injury.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...